YO Webinar – New Treatments for Geographic Atrophy and Causes of Vitreous Haemorrhage

YO Webinar - New Treatments for Geographic Atrophy and Causes of Vitreous Haemorrhage

Date: 29/07/2026 ()

Venue: Online, AUSTRALIA

Provider: Young Optometrists

Contact: Young Optometrists, [E] y.optoms@gmail.com, [P] 0431798060

Activity Outline

Join us for an informative evening with Adjunct Professor Hemal Mehta presenting on New Treatments for Geographic Atrophy and Dr Robert Chong presenting on Causes of Vitreous Haemorrhage. This practical session will focus on recognising key clinical signs, interpreting modern imaging, understanding the latest evidence for emerging treatments, and knowing when timely referral can make a difference.

Learn how recent advances in complement inhibition are changing the outlook for patients with geographic atrophy, including which patients may benefit from treatment, how to counsel them regarding expectations, the treatment burden, and potential risks. The session will also provide a practical and structured approach to assessing vitreous haemorrhage, including common causes, complications, investigations and referral pathways through real-world case discussions.

Learning Objectives

• Recognise and assess geographic atrophy secondary to age-related macular degeneration, including the clinical and imaging features associated with disease progression and the risk of future visual-function loss.
• Critically interpret the efficacy evidence from the pivotal OAKS, DERBY, GATHER1 and GATHER2 clinical trials, including reductions in geographic atrophy lesion growth and the influence of lesion location and treatment frequency on outcomes.
• Identify patients who may be appropriate for referral for consideration of geographic atrophy treatment, taking into account lesion characteristics, disease stage, visual function, fellow-eye status, treatment burden and patient preferences.
• Counsel patients regarding the anticipated benefits, limitations and risks of complement-inhibitor therapy, including the need for repeated intravitreal injections and monitoring for macular neovascularisation, intraocular inflammation, endophthalmitis, ischaemic optic neuropathy and retinal vasculitis.
• Recognise the common signs and symptoms of vitreous haemorrhage and develop an appropriate clinical assessment.
• Differentiate the major causes of vitreous haemorrhage, including retinal vascular disease, posterior vitreous detachment, trauma and other retinal pathology.
• Understand the natural history, investigation and potential complications of vitreous haemorrhage to guide management and referral decisions.
• Apply clinical knowledge through case-based discussions to optimise patient care and referral pathways.

Max CPD hours awarded: 3.5

Session Information